beta-alanine has been researched along with Ventricular Dysfunction, Left in 2 studies
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegret, JM | 1 |
| Viñolas, X | 1 |
| Arias, MA | 1 |
| Martínez-Rubio, A | 1 |
| Rebollo, P | 1 |
| Ràfols, C | 1 |
| Martínez-Sande, JL | 1 |
| Panchenko, EP | 1 |
1 review available for beta-alanine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
[Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagu | 2011 |
1 other study available for beta-alanine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
New oral anticoagulants vs vitamin K antagonists: benefits for health-related quality of life in patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabig | 2014 |